Literature DB >> 6601137

Endotoxin-induced T lymphocyte proliferation.

S N Vogel, M L Hilfiker, M J Caulfield.   

Abstract

The lymphocyte response to endotoxin (LPS) has been attributed largely to the action of this agent as a polyclonal activator of B lymphocytes. In this study we found that a cloned murine interleukin 2-dependent cytotoxic T cell line, CT 6, proliferates in response to LPS, thus providing the first evidence that T cells can be stimulated directly by LPS. The response was dose and time dependent and was blocked by polymyxin B, an inhibitor of LPS-induced mitogenesis. The fact that this is a cloned T cell line, free of other potentially contaminating lymphoid cell types, precludes the possibility that this proliferation is due to contaminating B lymphocytes or is mediated by macrophage-derived products such as interleukin 1. Moreover, highly purified splenic T lymphocyte populations (purified by negative/positive selection or by a rigorous column purification procedure) contain a small subpopulation (approximately 3%) of T cells that proliferate in response to LPS. This population is missing in the endotoxin-hyporesponsive C3H/HeJ mouse. As was observed in the CT 6 line, proliferation of splenic T cells in response to LPS was inhibited by polymyxin B. Furthermore, treatment of LPS-stimulated T cells with anti-T cell antibodies plus complement blocks the uptake of 3H-thymidine by these cultures. Exogenous interleukin 1 failed to stimulate the T cell cultures comparably to LPS and therefore cannot account for the degree of stimulation observed. These findings support and extend previous findings that suggested a role for an endotoxin-sensitive T cell population in the induction of certain responses, such as LPS-induced adjuvanticity of the lymphocyte-dependent LPS induction of macrophage procoagulant activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601137

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

Review 1.  The biology of endotoxin.

Authors:  H Heine; E T Rietschel; A J Ulmer
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

2.  T-helper functions in lines of mice selected for high or low antibody production (Selection III): modulation by anti-CD4+ monoclonal antibody.

Authors:  M H Reis; O M Ibanez; W H Cabrera; O G Ribeiro; D Mouton; M Siqueira; J Couderc
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

3.  Involvement of gamma interferon in antibody enhancement by adjuvants.

Authors:  M J Odean; C M Frane; M Van derVieren; M A Tomai; A G Johnson
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

4.  Label-free characterization of white blood cells by measuring 3D refractive index maps.

Authors:  Jonghee Yoon; Kyoohyun Kim; HyunJoo Park; Chulhee Choi; Seongsoo Jang; YongKeun Park
Journal:  Biomed Opt Express       Date:  2015-09-09       Impact factor: 3.732

5.  Bacterial lipopolysaccharide both renders resistant mice susceptible to mercury-induced autoimmunity and exacerbates such autoimmunity in susceptible mice.

Authors:  M Abedi-Valugerdi; C Nilsson; A Zargari; F Gharibdoost; J W DePierre; M Hassan
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

6.  Histamine synthesis by mouse T lymphocytes through induced histidine decarboxylase.

Authors:  R Aoi; I Nakashima; Y Kitamura; H Asai; K Nakano
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

7.  Histamine synthesis by non-mast cells through mitogen-dependent induction of histidine decarboxylase.

Authors:  C Oh; S Suzuki; I Nakashima; K Yamashita; K Nakano
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

8.  Mechanism(s) of in vitro macrophage activation with Nocardia rubra cell wall skeleton: the effects on macrophage activating factor production by lymphocytes.

Authors:  T Masuno; S Hayashi; M Ito; T Ikeda; T Ogura; S Kishimoto; Y Yamamura
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 9.  TLR agonists: our best frenemy in cancer immunotherapy.

Authors:  Sabina Kaczanowska; Ann Mary Joseph; Eduardo Davila
Journal:  J Leukoc Biol       Date:  2013-03-08       Impact factor: 4.962

10.  Cyclic ADP-ribose is a second messenger in the lipopolysaccharide-stimulated proliferation of human peripheral blood mononuclear cells.

Authors:  Santina Bruzzone; Antonio De Flora; Cesare Usai; Richard Graeff; Hon Cheung Lee
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.